Thrombospondin (TSP) was evaluated for its effect on the capacity of h
uman A549 lung adenocarcinoma cells to invade and degrade fibrin gels.
Cells suspended in DMEM containing 0.01 units/mL plasminogen were add
ed to a 2.5 mm diameter well in a 2 mm thick fibrin gel. Various conce
ntrations of TSP were added either to the cells or to the gel. After 1
8 hours, the number of spread and gel-adherent cells were counted and
the diameter of the well was measured to determine the extent of tumor
-induced fibrinolysis. In the absence of TSP, the tumor cells were non
-adherent but catalyzed the rapid degradation of the fibrin gel, causi
ng the application well to increase in diameter several-fold. In contr
ast, addition of either TSP to the gel or to the cell suspension inhib
ited fibrinolysis in a dose-dependent manner and promoted attachment a
nd spreading of cells in the fibrin matrix. In contrast, fibronectin h
ad no effect. The effect of TSP on both tumor cell-associated fibrinol
ysis and cell adhesion was inhibited with an anti-TSP monoclonal antib
ody. The cell adhesive peptides CSVTCG, derived from the type 1 repeat
s of TSP, and GRGDS also had no effect on tumor cell-associated fibrin
olysis. TSP inhibited fibrinolysis by inhibiting tumor cell-secreted u
rokinase activity, but had no effect on total urokinase secreted- anti
gen. In contrast, cell-associated urokinase activity was protected fro
m inhibition by TSP. These results suggest that TSP may promote tumor
cell metastasis not only by promoting cell-attachment but also by prot
ecting tumor cell-fibrin emboli from degradation by tumor secreted- an
d host fibrinolytic enzymes. Additionally, cell-associated enzymes imp
ortant in matrix degradation are protected from inhibition by TSP.